AAPS 2011 Science Award Winners - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

AAPS 2011 Science Award Winners


AAPS Science Award Winners 2011
spacer
AAPS 2011 Science Award Winners
line
Jeffrey S. Barrett
Jeffrey S. Barrett, PhD, is a research professor in the University of Pennsylvania School of Medicine, and director of the Laboratory for Applied PK/PD at the Children's Hospital of Philadelphia (CHOP). His research focuses on developing mathematical models to guide the design and analysis of both translational science experiments and clinical trials. These studies are pivotal to the development of new medicines and to improve our understanding of disease biolog, he says. Dr. Barrett's group develops decision support tools that interface such models with hospital-based medical records systems to guide drug therapy in critically-ill children. Much of his effort has been focused in children with cancer where Dr. Barrett works with colleagues at CHOP to a find cure for infant leukemia.
line
Lipika Chablani
Lipika Chablani is a PhD candidate within the Department of Pharmaceutical Sciences at the College of Pharmacy and Health Sciences, Mercer University. Her thesis is on the Formulation of Novel Particulate Breast Cancer Vaccines using Spray Drying and In Vivo Evaluation of Vaccine Efficac. Lipika holds a M.S.in Industrial Pharmacy, College of Pharmacy and Health Sciences, and a B.Pharm from the K.M.Kundnani College of Pharmacy at Mumbai University.
line
FanLin Kong
FanLin Kong is enrolled in the PhD program of the University of Texas Graduate School of Biomedical Sciences. She also works as a graduate research assistant at the University of Texas M.D. Anderson Cancer Center. Her research interest is focused on radiopharmaceutical development in oncology. She will graduate by the end of this year and start her research career as an instructor at M.D. Anderson Cancer Center.
line
Jessie Lu
Wenjie Jessie Lu received her college education from Peking University in China, where she studied Biological Sciences. She is now a senior PhD student at Indiana University School of Medicine working with Dr David Flockhart in the Division of Clinical Pharmacology. She is interested in personalized medicine, with a research focus on breast cancer therapeutics, and her work has generated a number of first-author papers in peer-reviewed journals.
line
Limin Shi
Limin Shi, PhD, is a postdoctoral fellow at the Pharmaceutical Materials Science and Engineering Laboratory, College of Pharmacy, University of Minnesota. His research has been dedicated to improving the drug delivery and manufacturing properties using innovative particle engineering approaches. His scientific achievements are expected to benefit the society by helping the pharmaceutical industry to manufacture high-quality drug products in an efficient way.
line
Suprita A. Tawde
Tawde is a PhD candidate from Dr. Martin D’Souz's laboratory at Mercer University College of pharmacy and health sciences. Tawde holds a M.S. in pharmaceutical sciences from Mumbai University and spent three years at Cipla Ltd. Tawde is currently working on microparticulate ovarian cancer vaccine project.
line
Xiaoyu Yan
Yan is a PhD Candidate at the Department of Pharmaceutical Sciences, University at Buffalo, the State University of New York. His research work is focused on the pharmacokinetic and pharmacodynamic modeling of erythropoiesis-stimulating agents. His presented work is about using population modeling and simulation approach to assess the comparability between a Recombinant Human Epoetin Alfa and the Biosimilar HX575.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
29%
Oversee medical treatment of patients in the US.
10%
Provide treatment for patients globally.
6%
All of the above.
42%
No government involvement in patient treatment or drug development.
13%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?

Click here